Results
71,196 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 2 | Hafer EvanDirector, Founder, 10% Owner |  BRCCBRC Inc.Other acquisition or disposition · 10b5-1 plan | J | — 200 sh | Oct 15, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 2 | Hafer EvanDirector, Founder, 10% Owner | BRCCBRC Inc. Other acquisition or disposition · 10b5-1 plan | J | — 200 sh | Oct 15, 2026 |
| 2 | Prober Charles J.Director |  LIFLife360, Inc.Option exercise · 10b5-1 plan | M | $89K 7,930 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 2 | Bhatia Manish HPresident and COO |  MUMICRON TECHNOLOGY INCGrant or award | A | — 28.8K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 2 | Bhatia Manish HPresident and COO | MUMICRON TECHNOLOGY INC Grant or award | A | — 10.1K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 2 |  Huffman Steve LaddDirector, CEO & President, 10% Owner |  RDDTReddit, Inc.Option exercise · 10b5-1 plan | M | $438K 17.3K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 2 | Bhatia Manish HPresident and COO | MUMICRON TECHNOLOGY INC Option exercise | M | — 24.1K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 2 | Eddy Robert W.Director, President & CEO |  BJBJ's Wholesale Club Holdings, Inc.Option exercise · 10b5-1 plan | M | $211K 12.4K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 2 | Bhatia Manish HPresident and COO | MUMICRON TECHNOLOGY INC Option exercise | M | — 24.1K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 2 | Bhatia Manish HPresident and COO | MUMICRON TECHNOLOGY INC Grant or award | A | — 25.9K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 1 | Houston AndrewDirector, Co-CEO, 10% Owner |  DBXDROPBOX, INC.Derivative conversion · 10b5-1 plan | C | — 29.5K sh | Oct 15, 2026 traded Oct 12, 2026 |
| 1 | Huffman Steve LaddDirector, CEO & President, 10% Owner | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $114K 700 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 1 | Huffman Steve LaddDirector, CEO & President, 10% Owner | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $203K 1,300 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 1 |  Robinhood Markets, Inc.10% Owner |  RVIRobinhood Ventures Fund IOpen-market sale · 10b5-1 plan | SELL | $114K 4,537 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 1 | Robinhood Markets, Inc.10% Owner | RVIRobinhood Ventures Fund I Open-market sale · 10b5-1 plan | SELL | $110K 4,362 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 1 | Huffman Steve LaddDirector, CEO & President, 10% Owner | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $192K 1,200 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 1 | Huffman Steve LaddDirector, CEO & President, 10% Owner | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $82K 500 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 1 | Houston AndrewDirector, Co-CEO, 10% Owner | DBXDROPBOX, INC. Derivative conversion · 10b5-1 plan | C | — 29.5K sh | Oct 15, 2026 traded Oct 12, 2026 |
| 1 | Wang XiaodongDirector, Chair, Scientific Advisory Brd |  ONCBeOne Medicines Ltd.Option exercise · 10b5-1 plan | M | $1.14M 31.0K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 1 | Hansen GwennChief Scientific Officer |  NRIXNurix Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $36K 1,452 sh | Oct 15, 2026 traded Oct 15, 2026 |
| 0 | How AntoinetteChief Accounting Officer |  NXDRNextdoor Holdings, Inc.Derivative conversion · 10b5-1 plan | C | — 10.8K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 0 | How AntoinetteChief Accounting Officer | NXDRNextdoor Holdings, Inc. Option exercise · 10b5-1 plan | M | — 10.8K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 0 | How AntoinetteChief Accounting Officer | NXDRNextdoor Holdings, Inc. Derivative conversion · 10b5-1 plan | C | — 10.8K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 0 | Hafer EvanDirector, Founder, 10% Owner | BRCCBRC Inc. Derivative conversion · 10b5-1 plan | C | — 200 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 0 | How AntoinetteChief Accounting Officer | NXDRNextdoor Holdings, Inc. Option exercise · 10b5-1 plan | M | — 10.8K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 0 | Larson Keith DGeneral Counsel and Secretary |  VGVenture Global, Inc.Option exercise · 10b5-1 plan | M | — 395.0K sh | Oct 15, 2026 traded Oct 14, 2026 |
| 0 | Larson Keith DGeneral Counsel and Secretary | VGVenture Global, Inc. Option exercise · 10b5-1 plan | M | $68K 5,300 sh | Oct 15, 2026 traded Oct 15, 2026 |
| 0 | Hafer EvanDirector, Founder, 10% Owner | BRCCBRC Inc. Derivative conversion · 10b5-1 plan | C | — 200 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 0 | Larson Keith DGeneral Counsel and Secretary | VGVenture Global, Inc. Option exercise · 10b5-1 plan | M | $332K 395.0K sh | Oct 15, 2026 traded Oct 14, 2026 |
| 0 |  Silverman JoshDirector, Executive Chair of the Board |  ETSYETSY INCOption exercise · 10b5-1 plan | M | $4,429 417 sh | Oct 15, 2026 traded Oct 15, 2026 |
| 0 | Eddy Robert W.Director, President & CEO | BJBJ's Wholesale Club Holdings, Inc. Option exercise · 10b5-1 plan | M | — 172.2K sh | Oct 15, 2026 traded Oct 14, 2026 |
| 0 | Hafer EvanDirector, Founder, 10% Owner | BRCCBRC Inc. Derivative conversion · 10b5-1 plan | C | — 200 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 0 | Ray Michael CharlesSVP, Chief Legal Officer | MUMICRON TECHNOLOGY INC Grant or award · 10b5-1 plan | A | — 18.2K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 0 | Hafer EvanDirector, Founder, 10% Owner | BRCCBRC Inc. Derivative conversion · 10b5-1 plan | C | — 200 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 0 | Murphy Andrew JCo-Chief Scientific Officer |  REGNREGENERON PHARMACEUTICALS, INC.Option exercise · 10b5-1 plan | M | — 17.0K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 1,452 sh | Oct 15, 2026 traded Oct 15, 2026 |
| 0 | Huffman Steve LaddDirector, CEO & President, 10% Owner | RDDTReddit, Inc. Option exercise · 10b5-1 plan | M | — 17.3K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 0 | Hansen GwennChief Scientific Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $2,701 1,452 sh | Oct 15, 2026 traded Oct 15, 2026 |
| 0 | Ray Michael CharlesSVP, Chief Legal Officer | MUMICRON TECHNOLOGY INC Grant or award · 10b5-1 plan | A | — 16.3K sh | Oct 15, 2026 traded Oct 13, 2026 |
| 0 | Prober Charles J.Director | LIFLife360, Inc. Option exercise · 10b5-1 plan | M | — 7,930 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 0 | Hafer EvanDirector, Founder, 10% Owner | BRCCBRC Inc. Other acquisition or disposition · 10b5-1 plan | J | — 200 sh | Oct 15, 2026 traded Oct 14, 2026 |